Burcu Aslan Candır

7PUBLICATIONS
14CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 15, 2026
Factors Affecting Prognosis in Patients with Extramedullary Myeloma: A Single-Center Experience.

|May 04, 2026
Impact of Dyslipidemia on Allogeneic Transplantation Outcomes and Cardiovascular Mortality in Patients with Acute Leukemias in the Post-Transplant Cyclophosphamide Era.

|Mar 14, 2026
Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey.

Mehmet Bakırtaş, İlhami Berber, İpek Yönal Hindilerden

|Sep 13, 2025
Cholesterol Levels Are Not Associated with Peripheral Blood Stem Cell Mobilization in Healthy Donors.

Sema Seçilmiş, Burcu Aslan Candır, Ersin Bozan

|Jul 20, 2024
Early Tapering of Cyclosporine Is Feasible in Haploidentical Stem Cell Transplantation: A Single Center Experience.

Samet Yaman, Semih Başci, Ersin Bozan

|Jan 12, 2022
Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease.

Burcu Aslan Candır, Tuğçe Nur Yiğenoğlu, Merih Kızıl Çakar

Pageof 2

Frequent Collaborators

2 joint publications

Samet Yaman

2 joint publications

Merih Kızıl Çakar

2 joint publications

Mehmet Sinan Dal

2 joint publications

Sema Seçilmiş